| |
| |
|
| Insider
Information: |
Rhodes Jason P |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,000 |
|
|
Indirect Shares
|
23,308,240 |
|
|
| Direct
Value |
$202,860 |
|
|
|
Indirect Value
|
$336,540,122 |
|
|
| Total
Shares |
23,446,240 |
|
|
| Total
Value |
$336,742,982 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -2.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
President, CFO and Tre... |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Premium* |
|
|
Replimune Group Inc |
REPL |
Director |
2018-07-24 |
0 |
2021-01-26 |
3,228,912 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
Director |
|
0 |
2021-09-29 |
8,279,484 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
|
0 |
2024-03-01 |
6,545,479 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director |
|
0 |
2021-02-05 |
5,254,365 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-03-01 |
4 |
AS |
$30.05 |
$1,398,347 |
I/I |
(46,534) |
847,388 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-28 |
4 |
AS |
$24.83 |
$4,741,804 |
I/I |
(190,920) |
864,487 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-27 |
4 |
AS |
$24.38 |
$8,998,426 |
I/I |
(368,699) |
877,806 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-26 |
4 |
AS |
$23.59 |
$5,886,673 |
I/I |
(248,219) |
903,527 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-23 |
4 |
AS |
$22.70 |
$4,470,266 |
I/I |
(196,928) |
920,843 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-22 |
4 |
AS |
$22.66 |
$2,704,698 |
I/I |
(119,360) |
6,512,104 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-21 |
4 |
AS |
$22.44 |
$4,164,817 |
I/I |
(184,501) |
6,631,464 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-20 |
4 |
AS |
$22.71 |
$3,852,653 |
I/I |
(169,539) |
6,815,965 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-16 |
4 |
AS |
$23.14 |
$3,765,040 |
I/I |
(162,707) |
6,985,504 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-02-15 |
4 |
AS |
$23.88 |
$4,249,600 |
I/I |
(177,906) |
7,148,211 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • – |
2022-12-12 |
4 |
B |
$10.70 |
$10,000,017 |
I/I |
934,581 |
934,581 |
2.1 |
% |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-29 |
4 |
AS |
$24.59 |
$407,850 |
I/I |
(16,586) |
608 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-28 |
4 |
AS |
$25.24 |
$330,972 |
I/I |
(13,113) |
638 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-27 |
4 |
AS |
$25.70 |
$1,320,697 |
I/I |
(51,389) |
662 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-24 |
4 |
AS |
$25.84 |
$747,161 |
I/I |
(28,916) |
757 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-23 |
4 |
AS |
$26.13 |
$1,972,127 |
I/I |
(75,465) |
811 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-22 |
4 |
AS |
$25.89 |
$792,705 |
I/I |
(30,617) |
951 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-06-24 |
4 |
AS |
$25.77 |
$801,618 |
I/I |
(31,008) |
608 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-06-23 |
4 |
AS |
$25.08 |
$1,587,548 |
I/I |
(62,609) |
666 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-06-22 |
4 |
AS |
$24.76 |
$1,461,479 |
I/I |
(58,577) |
782 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-06-21 |
4 |
AS |
$24.82 |
$1,586,940 |
I/I |
(63,892) |
890 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-14 |
4 |
AS |
$26.40 |
$622,995 |
I/I |
(23,413) |
0 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-13 |
4 |
AS |
$25.09 |
$1,085,744 |
I/I |
(43,145) |
23,413 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-12 |
4 |
AS |
$26.07 |
$1,938,229 |
I/I |
(74,124) |
66,558 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-09 |
4 |
AS |
$27.57 |
$1,205,948 |
I/I |
(43,681) |
140,682 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
